Kevzara (sarilumab) can produce noticeable improvements in joint pain and stiffness within the first few weeks of treatment, but it takes 14 to 16 weeks to reach full strength in your body. Some people feel a difference after their first or second injection, while others need several months before the benefits become clear.
What Happens in the First Few Weeks
Kevzara starts working on inflammation almost immediately. Within about four days of the first injection, levels of C-reactive protein, a key marker of inflammation in the blood, can drop to normal. That’s fast compared to many other biologics. In clinical trials, patients reported measurable improvements in pain, fatigue, and overall well-being as early as two weeks after starting treatment.
But feeling better on a blood test and feeling better in your daily life aren’t always the same thing. Those early weeks are when some people notice their morning stiffness easing or their joints feeling a bit less swollen, while others don’t notice much change yet. Both responses are normal at this stage.
The 14 to 16 Week Mark
Kevzara is injected every two weeks, and with each dose the drug accumulates in your system. According to FDA pharmacology data, the drug reaches steady-state levels (meaning a consistent, therapeutic concentration) at around 14 to 16 weeks. Full trough levels, the lowest point between doses, stabilize at 18 to 20 weeks. By that point, the medication has built up to roughly two to three times the level of a single dose.
This is why rheumatologists typically evaluate whether Kevzara is truly working for you after about three to four months. Judging the drug too early can be misleading, since it hasn’t yet reached its full potential. If you’re still experiencing significant symptoms at the four-month mark, your doctor may adjust the dose or consider alternatives.
How the Two Doses Compare
Kevzara comes in 150 mg and 200 mg strengths. The 200 mg dose consistently performs better in clinical trials. In a pooled analysis of four randomized trials involving over 2,600 patients, the 200 mg dose ranked highest for achieving meaningful symptom reduction. Most people start on 200 mg every two weeks, with the option to drop to 150 mg if side effects like low white blood cell counts or elevated liver enzymes become an issue.
Both doses are effective. The 150 mg version simply produces a somewhat lower response rate, not a slower one. The timeline for reaching steady state is similar regardless of which dose you’re on.
Long-Term Joint Protection
Beyond symptom relief, one of Kevzara’s most important jobs is slowing or stopping the structural damage that rheumatoid arthritis does to your joints over time. In a major clinical trial called MOBILITY, patients on the 200 mg dose plus methotrexate showed significantly less joint damage on X-rays at one year compared to those on methotrexate alone.
Five-year follow-up data from that same trial showed the benefit was durable. Patients who started on the higher dose early had the least joint damage at five years. Patients who initially received placebo and then switched to Kevzara at the one-year mark showed a clear inflection point: their joint damage slowed markedly after switching, but they never fully caught up to those who started treatment earlier. This is a strong argument for not waiting too long to assess whether the drug is working and for starting effective treatment as soon as possible.
Blood Tests You’ll Need Early On
Because Kevzara can lower white blood cell counts (specifically neutrophils) and raise liver enzymes, your doctor will run blood tests before you start and then again at 4 to 8 weeks. After that initial check, routine monitoring continues every three months. These early labs are one reason your medical team will be in close contact during the first couple of months, and they’re a practical part of the timeline you should plan for.
If your neutrophil count drops too low or liver enzymes rise significantly, your doctor may pause treatment or switch you to the lower dose. These adjustments are common and don’t necessarily mean Kevzara isn’t the right drug for you.
A Realistic Timeline to Keep in Mind
Here’s a practical way to think about what to expect:
- Days 1 to 14: Inflammation markers in your blood may drop quickly. Some people notice early symptom relief, others don’t yet.
- Weeks 2 to 6: Improvements in pain, fatigue, and stiffness may begin. Your first follow-up blood tests happen during this window.
- Weeks 14 to 16: The drug reaches full steady-state concentration. This is a reasonable point to assess whether it’s providing meaningful relief.
- Weeks 18 to 20: Trough levels stabilize completely. If Kevzara is working for you, this is typically when you’ll feel its full effect.
- Months 6 to 12: Ongoing benefits in symptom control and measurable slowing of joint damage on imaging.
Patience during the first few months is important, but so is honest communication with your rheumatologist. If you’re seeing no improvement at all by the three-month mark, that’s worth discussing. The goal is to find the right treatment as quickly as possible, not to wait indefinitely on one that isn’t delivering results.